Amarin Corporation PLC (AMRN) 首席执行官 John Thero 于 2019年 第二季度业绩 - 收益电话会议记录

Amarin Corporation PLC (NASDAQ:AMRN) Q2 2019 Earnings Conference Call July 31, 2019 7:30 AM ET Amarin Corporation PLC(纳斯达克股票代码:[AMRN])2019年第二季度收益电话会议2019年7月31日美国东部时间上午7:30 公司参与者 Elisabeth Schwartz - Senior Director, IR John Thero - President, CEO & Director Michael Kalb - CFO, SVP & Assistant Secretary 伊丽莎白施瓦茨 - IR高级总监 John Thero - 总裁,首席执行官兼董事 Michael Kalb - 首席财务官,高级副总裁兼助理秘书 电话会议参与者 Louise Chen - Cantor...

Amarin Corporation plc。 (AMRN) 首席执行官 John Thero 在 2019年BMO 处方成功医疗保健会议上发表 (成绩单)

Amarin Corporation plc. (NASDAQ:AMRN) 2019 BMO Prescription For Success Healthcare Conference June 25, 2019 11:20 AM ET Amarin Corporation plc。 (纳斯达克股票代码:[AMRN])2019年BMO处方成功医疗会议2019年6月25日美国东部时间上午11:20 公司参与者 John Thero - President and CEO John Thero - 总裁兼首席执行官 电话会议参与者 Hello. President and CEO of Amarin, who'll give a presentation for about 15-20 minutes, I think, and then we'll follow-up with some Q&A. John has been at Amarin for almost 10 years, and CEO for the past fiv...

Amarin Corporation plc (AMRN) 首席执行官 John Thero 出席高盛第 40 届全球医疗保健大会 (成绩单)

Amarin Corporation plc (NASDAQ:AMRN) Goldman Sachs 40th Annual Global Healthcare Conference Call June 12, 2019 4:20 PM ET Amarin Corporation plc(纳斯达克股票代码:[AMRN])Goldman Sachs第40届全球医疗保健大会电话会议2019年6月12日东部时间下午4:20 公司参与者 John Thero - President and Chief Executive Officer John Thero - 总裁兼首席执行官 电话会议参与者 Hello, everybody. Thank you for joining me today. My name is John Thero, I’m President and CEO of Amarin. As we go through this presentation, I hope you will get a sense for ...

Amarin Corporation plc (AMRN) 首席执行官 John Thero 出席 Jefferies 2019年 医疗保健会议 (成绩单)

Amarin Corporation plc (NASDAQ:AMRN) Jefferies 2019 Healthcare Conference June 6, 2019 9:30 AM ET Amarin Corporation plc(纳斯达克股票代码:[AMRN])Jefferies 2019医疗保健会议2019年6月6日美国东部时间上午9:30 ****高管 John Thero - President, Chief Executive Officer John Thero - 总裁,首席执行官 ****分析师 Michael Yee - Jefferies Michael Yee - Jefferies Michael Yee Thank you. Good morning everyone. As you know, I am Michael Yee, Managing Director and senior biotechnology analyst at Jefferies. And I am very happy to introduce the Pr...